Remote patient monitoring is transforming respiratory care by shifting treatment from reactive hospital visits to proactive intervention at home. This technology-driven approach particularly benefits the 328 million adults worldwide living with chronic obstructive pulmonary disease, where timely detection of symptom changes can prevent costly emergency admissions and improve quality of life.
Artificial intelligence algorithms now process continuous streams of patient data from wearable devices and home monitoring equipment, identifying patterns that predict respiratory exacerbations before patients experience severe symptoms. The evidence demonstrates particularly strong outcomes for COPD management, where telemonitoring systems have consistently reduced both disease flare-ups and hospitalization rates. However, effectiveness varies significantly across different respiratory conditions, with asthma showing more mixed results and newer applications in interstitial lung diseases still generating preliminary data.
This systematic approach to remote care represents a fundamental shift toward precision respiratory medicine, where treatment decisions rely on real-time physiological data rather than episodic clinical encounters. The technology integrates seamlessly with existing pulmonary rehabilitation programs and non-invasive ventilation therapies, creating comprehensive care ecosystems. Yet implementation faces substantial barriers including patient digital literacy gaps, healthcare system integration challenges, and unresolved questions about long-term cost-effectiveness. The COVID-19 pandemic accelerated adoption and proved feasibility, but sustainable integration requires addressing persistent inequities in technology access and developing robust reimbursement frameworks that support continuous monitoring rather than traditional fee-for-service models.